Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
ID: 360918Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360918
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers, including Comprehensive, Clinical, and Basic Cancer Centers. Applicants must demonstrate a substantial base of NIH cancer-focused funding, with requirements of $10 million for Clinical and Comprehensive Centers, and $6 million for Basic Centers for new applicants, while renewal applicants must also meet a $10 million threshold. These grants are crucial for advancing interdisciplinary research to reduce cancer incidence, mortality, and morbidity, providing resources for scientific leadership, shared facilities, and administrative costs over a five-year term, with a possible two-year extension based on merit. Interested institutions can contact the Office of Cancer Centers at ncicenters-r@mail.nih.gov for further information, with applications due by September 25, 2028.

    Point(s) of Contact
    ncicenters-r@mail.nih.gov
    Files
    Title
    Posted
    PAR-25-444-Full-Announcement.html
    The Department of Health and Human Services, National Institutes of Health, and National Cancer Institute invite applications for Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (PAR-25-444). This funding opportunity, a reissue of PAR-21-321, aims to support Comprehensive, Clinical, and Basic Cancer Centers in their efforts to reduce cancer incidence, mortality, and morbidity through interdisciplinary research. The grant provides resources for scientific leadership, shared facilities, administrative costs, planning, and developmental funds. Eligibility requires a substantial base of NIH cancer-focused funding ($10M for Clinical/Comprehensive, $6M for Basic new applicants, $10M for all renewal applicants) and adherence to six essential characteristics, including physical space, organizational capabilities, transdisciplinary collaboration, cancer focus, institutional commitment, and strong Center Director leadership. The grant term is five years, with an optional two-year extension based on merit.
    Similar Opportunities
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers through the P30 funding mechanism. This initiative seeks to enhance collaborative cancer research across various domains, including basic laboratory, clinical, and prevention research, with eligibility extending to Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Cancer Centers that demonstrate significant research capabilities and community engagement. The funding, which has an award ceiling of $1.5 million, is intended to foster transdisciplinary research collaboration, create shared resources, and ensure equitable participation in cancer research across diverse populations. Interested applicants must submit their proposals by January 7, 2026, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers under the P30 activity code. These grants are designed to foster excellence in cancer research by integrating diverse research activities and enhancing collaboration among institutions, with eligible applicants including various educational and community organizations. The CCSGs emphasize a transdisciplinary approach to cancer research, with funding amounts of up to $1.2 million for Basic Cancer Centers and $1.4 million for Clinical Cancer Centers per year, potentially extending over five years based on merit. Interested parties can find more information and application details at the NIH website, and inquiries can be directed to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV. The application deadline is set for October 12, 2121.
    Forecast to Publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) aimed at NCI-designated Cancer Centers. This initiative invites applications from small businesses to support various types of Cancer Centers, including Comprehensive, Clinical, and Basic Cancer Centers, with the goal of enhancing cancer research capabilities and fostering collaboration across institutional boundaries. The CCSGs are crucial for advancing the understanding of cancer and developing effective prevention, diagnosis, and treatment strategies. Interested applicants can reach out to the Office of Cancer Centers at the National Cancer Institute via email at ncicenters-r@mail.nih.gov or by phone at 240-276-5600. The estimated synopsis will be posted on October 1, 2025, with applications closing on January 25, 2026, and awards expected to be made by December 1, 2026.
    Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)" aimed at fostering long-term partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs). This initiative seeks to enhance cancer research by addressing disparities in cancer outcomes and promoting outreach and engagement across diverse populations. The program anticipates awarding approximately 12 cooperative agreements, with a minimum funding amount of $850,000, and key deadlines include an estimated synopsis close date of January 16, 2026, and an expected award date of September 1, 2026. For further inquiries, interested applicants can contact Dr. Sandra San Miguel-Majors at 240-276-5977 or via email at ncicpachU54@mail.nih.gov.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Core Centers for Clinical Research (CCCR)" aimed at advancing methodological sciences in clinical research related to musculoskeletal, rheumatic, and skin diseases. This initiative seeks to establish centers that will focus on the prevention, diagnosis, and treatment of these conditions, emphasizing the development of novel methods and metrics while ensuring community representation throughout the research process. Eligible applicants include small businesses, with no cost-sharing or matching requirements, and the estimated project start date is set for July 1, 2027. Interested parties can reach out to Dr. Melissa C. Green Parker at melissa.greenparker@nih.gov or by phone at 240-755-3031 for further information, with the application period expected to close on September 25, 2026.
    Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Cancer Prevention and Control Clinical Trials Planning Grant Program (R34), aimed at supporting the planning of clinical trials that enhance cancer prevention, detection, and survivorship. This program seeks to address critical gaps in preliminary data, participant recruitment strategies, and study designs necessary for finalizing trial protocols, thereby facilitating effective cancer intervention trials aligned with public health goals. Eligible organizations, including higher education institutions and nonprofits, can apply for funding of up to $225,000 per year for a maximum of three years, with a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application. Interested applicants should note the open submission date of January 25, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Cancer Intervention and Surveillance Modeling Network (CISNET) through a Notice of Funding Opportunity (NOFO) aimed at collaborative research projects utilizing simulation and modeling techniques for specific cancer types. The primary objective is to develop evidence-based tools that inform efficient strategies for cancer control, focusing on comparative modeling for cancers such as bladder, breast, cervix, colon/rectum, esophagus, gastric, multiple myeloma, lung, prostate, and uterine. This initiative is crucial for enhancing cancer control efforts and improving outcomes in at-risk populations. The NIH plans to allocate approximately $9.438 million in FY 2026 to fund up to eight awards, with applications due by February 11, 2026. Interested applicants can reach out to Natasha Stout at natasha.stout@nih.gov for further information.
    NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the NCI Small Grants Program for Cancer Research (R03) for the years 2023 to 2025. This funding opportunity is designed to support small-scale research projects on cancer that can be completed within a two-year timeframe and with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies or technologies. Grants of up to $50,000 per year are available to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations. Interested parties should submit their applications electronically via Grants.gov, with the first submission deadline having been January 22, 2023, and subsequent deadlines continuing through 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NCI Small Grants Program for Cancer Research (R03), aimed at supporting short-term cancer research projects that require limited resources. This funding opportunity encourages diverse research efforts, including pilot studies, secondary data analyses, and the development of research methodologies, with a maximum budget of $50,000 per year for projects lasting up to two years. The program is designed to address significant knowledge gaps in cancer research and is open to a wide range of applicants, including public, private, and foreign entities. Interested parties should note that the application period opens on January 24, 2025, with a submission deadline of February 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.